Day: April 4, 2018

Which were published in the journal BMC Public Health articles.

Alcohol-related mortality increases in deprived regions of England and Wales socioeconomically Researchers at the University of Sheffield have found there are substantially increased death rates from alcohol-related illnesses in socioeconomically deprived regions of England and Wales. The results, which were published in the journal BMC Public Health, discovered that the mortality prices of women and men in the most deprived regions of England and Wales were over four instances the rates in much less deprived areas articles . The outcomes contradict several previous surveys which have regularly maintained that there is no excess alcohol consumption in even more socioeconomically deprived groups. Read More

Announced today that Merrimack Pharmaceuticals.

announced today that Merrimack Pharmaceuticals, Inc. Can be using ACD's RNAscope technology to select patients for its Phase 2 clinical trial of its product applicant MM-121. Merrimack shall utilize RNAscope to identify individuals with heregulin positive, locally advanced or metastatic non-small cell lung tumor, causeing this to be Merrimack's initial MM-121 trial to include only patients with a high heregulin biomarker profile. In prior MM-121 Phase 2 clinical trials, heregulin-positive patients, determined by RNAscope, possess demonstrated significant therapeutic benefits when treated with a combination of MM-121 and standard therapies. These trials have repeatedly demonstrated the potential of heregulin as a promising biomarker in predicting the therapeutic great things about MM-121. Read More